• TBC

Learning Outcomes:

• Recognise the benefits of a collaborative approach to the biosafety risk assessment of ATMPs
• Learn about latest developments at the ATMP networks
• ATIMPs horizon scanning  - what ATIMPs will we be delivering next?
• Understand key implications of the new Modular Manufacture and Point of Care regulations
• Understand the unique features and challenges of cross-institutional ATMP trial delivery

• TBC

Learning Outcomes:

• Understand the complementary roles of CRDCs and CRFs in clinical research delivery
• Identify opportunities for collaboration that enhance efficiency and patient impact.
• Explore practical models for joint planning, resource sharing, and governance.
• Define actionable steps for strengthening local and national CRDC–CRF partnerships.

• TBC

Learning Outcomes:

• Understand the regulatory and ethical framework governing medical device trials.
• Gain insight into the endtoend setup process for a medical device clinical investigation.
• Explore the key operational roles, responsibilities, and documentation requirements within a device trial.
• Demonstrate understanding of site readiness and infrastructure needs for medical device trials, including staff training, equipment, participant-facing technology, and data management systems required for highquality delivery.
• Gain insight into common challenges encountered in delivering medical device trials.
• Apply bestpractice approaches to participant engagement and trial conduct.

• TBC

Learning Outcomes:

• Understand key EDI concepts and implementation in practice and how they can be applied in clinical research settings, drawing on examples from the NIHR King’s CRF and Research Delivery Units training programme, including cultural intelligence, trans* awareness, and addressing health inequalities.
• Identify practical strategies to improve accessibility and inclusivity within clinical research and PPIE activities
• Explore approaches to co-producing training and publications with public involvement members, and consider effective ways of working with community partners and seldom-heard groups.
• Critically reflect on and evaluate the inclusiveness of existing PPI plans and activities, identifying gaps and opportunities for embedding EDI within participants’ own research or organisations.

• TBC

Learning Outcomes:

• TBC

• TBC

Learning Outcomes:

• Gain insight into the operational structure of IQVIA Central Labs in the UK and Ireland and their role in transnational clinical research.
• Understand how IQVIA laboratory manuals are developed, who contributes to their content, and how they align with protocol requirements.
• Explore the design, sustainability considerations, and logistics of IQVIA kit assembly, storage, distribution and ordering processes.
• Learn about common sample queries, errors and rejection reasons encountered at central lab receipt (e.g., wrong tube, mislabeling, missing transmittal paperwork).
• Identify best practices for pre-analytical sample handling that reduce errors and improve downstream analysis quality.
• Gain awareness of the most common causes behind missing or delayed results and how these can be mitigated at site level.
• Develop a deeper understanding of the end-to-end sample journey from patient draw → site processing → central lab receipt → analysis and reporting.
• Discover opportunities for improved communication and collaboration between CRFs and IQVIA to support sample quality, efficiency, and research outcomes.
• Apply learning from the session to optimise local workflows, staff training and internal lab quality processes.

• TBC

Learning Outcomes:

• Gain insight into the different perspectives of public contributors on PPI payments
• Appreciate the challenges and solutions of PPIE payments for public contributors
• Learn how to develop a realistic PPI budget
• Hear examples of how CRFs have implemented solutions to payment barriers
• Contribute to further work in this area

• TBC

Learning Outcomes:

• Hear lived experience of seeking care or trial access across borders.
• Understand the current landscape of cross-border clinical trial collaboration, including existing pathways and limitations, with examples from the island of Ireland.
• Describe referral processes for enrolling trial patients across borders and identify barriers in accessing studies.
• Explain post-trial and during-trial care pathways for patients returning to their home jurisdiction.
• Co-develop practical recommendations to improve connectivity, streamline processes, and enhance patient access to research.

• TBC

Learning Outcomes:

• Explore key updates in Version 6 of the UKCRF Network Emergency Scenario Training Guidelines and the rationale for these changes.
• Explore effective strategies and approaches to support staff learning and engagement during emergency scenario training.
• Identify at least one priority action to enhance emergency scenario training within their own practice area

• TBC

Learning Outcomes:

• Gain an understanding of the key aspects of the Quality Assurance role in a CRF
• Learn how to begin creating and embedding quality management in a research facility
• Discover UKCRF Network tools designed to support the QA role and learn how they can be used
• Contribute ideas and suggestions for a new QA Role Outline tool to be developed by the QA Work Group
• Take part in a Q&A session

• TBC

Learning Outcomes:

• Understand what the evidence says about positive health and wellbeing
• Recognise how lifestyle medicine and behaviour change science support sustainable health improvements
• Identify one key pillar of health most relevant to them personally
• Leave with practical examples of small, achievable changes that can realistically fit into everyday working life

• TBC

Learning Outcomes:

• Understand the purpose and structure of the Advanced Therapy Clinical Trials Capability Framework and how it supports site readiness and system-wide capacity building.
• Gain insight into current developments and collaborative work underway to strengthen ATMP trial capability across a trans-national landscape.
• Explore the expansion of advanced therapies beyond haematology and oncology, including emerging therapeutic areas and clinical indications.
• Identify the key operational, regulatory, and governance requirements for delivering ATIMPs safely and compliantly.
• Develop awareness of the different ATIMP modalities (e.g. cell therapies, gene therapies, tissue-engineered products) and their distinct delivery considerations.
• Apply practical considerations for workforce planning, infrastructure, pharmacy, and clinical oversight when preparing to open or scale ATMP trials.

• TBC

Learning Outcomes:

• Understand how UK R&D Directorates operate within hospitals, including their governance structures, approval pathways, and integration with wider NHS Trust responsibilities.
• Examine models of collaboration between UK R&D teams and universities, identifying features that enable effective partnership working and considering which elements may translate well to the Irish context.
• Explore established approaches to capacity building within the UK, such as structured development pathways and workforce supports, and reflect on how comparable approaches could be adapted to strengthen capacity within Irish hospital and regional settings.
• Gain insight into the Research Passport system, how it supports academic researchers working in hospitals, and how similar streamlined processes could inform practices in Ireland.
• Understand how UK R&D offices interface with legal, data protection, information governance, and wider data infrastructure teams, and consider how strong data foundations can enable research activity at scale.
• Identify practical, highvalue opportunities that Irish hospitals and regions can adopt, focusing on approaches that are achievable within existing structures and that build momentum for developing R&D functions.
• Consider effective ways of communicating research needs and opportunities to stakeholders, supporting shared understanding and informed decisionmaking around future investment and development
• Gain a deeper understating into the UK R&D funding landscape and how this has evolved over time.

• TBC

Learning Outcomes:

• Understand the core principles and defining features of decentralised clinical trials;
• Explore, Identify and Learn together the unique challenges and opportunities associated with decentralised clinical trials – for example funding utilization; regulatory and oversight considerations; impact on rare disease populations; contracting considerations; etc.;
• Discover together appreciations as to why the traditional contractual approach (for decentralised trials) may not work and simultaneously Gain Insights in how to approach likely new structural questions;
• Identify and discuss together the operational workflows and SOPs required to deliver decentralised trials effectively;
• Explore together what kind of digital tools and platforms are more suitable for decentralised trial delivery – for example wearable connected devices;
• Apply decentralised trial principles to realworld scenarios; and
• Apply the learnings of the session into an open-forum discussion and answer style conclusion.

• TBC

Learning Outcomes:

• Learn about ways in which aspects of research delivery are increasingly moving toward digital technologies
• Understand the regulatory expectations for computerised systems
• Gain insight through case studies into the practical challenges of moving from paper-based to electronic systems
• Explore and discuss the barriers and facilitators to transitioning to digital technologies.

• TBC

Learning Outcomes:

• Showcase how good communication strengthens research delivery, recruitment, public engagement, and partnerships.
• Offer simple, adaptable best‑practice guidance for non‑comms staff (e.g., writing clear participant-facing materials, contributing to comms stories, using images ethically, engaging with social media safely).
• Feature short case studies from CRFs demonstrating strong cross-team collaboration.
• Include a practical element such as rewriting a short piece of text or identifying suitable case study stories to support recruitment and visibility.

• TBC

Learning Outcomes:

• Identify what professionalism means in research nurses and midwifery, and work through two case studies, matching CPD opportunities to the skills/experience.
• Lean about alternative ways to earn CPD points, outside of mainstream courses.
• Understand the CPD requirements in Ireland and the UK, and how the legal obligation of earning CPD in Ireland is being implemented for research nurses and midwives.
• Build the UKCRF CPD database for new and alternative opportunities.

• TBC

Learning Outcomes:

• Understand what effective community engagement looks like
• Learn how to map relevant communities and stakeholders
• Identify practical approaches and engagement methods to meet specific community needs
• Hear case studies on co-designing community engagement events
• Learn how to evaluate impact and effectiveness of community engagement

• TBC

Learning Outcomes:

• TBC

• TBC

Learning Outcomes:

• Recognise the key updates to the new UK GCP regulations relevant to the PI role
• Hear first-hand insights from experienced nonmedic PIs about their journey, leadership development, and practical strategies for trial delivery.
• Explore how CRFs can strengthen support for nonmedic PIs and share group reflections.
• Engage in Q&A to clarify issues, explore solutions, and identify any next steps for PI leadership.

• TBC

Learning Outcomes:

• Explore how recent changes to clinical trials regulations are affecting the setup and delivery of studies across different roles and settings.
• Consider the practical implications of the regulatory changes.
• Discuss common challenges and positive impacts of the new regulations.
• Share experiences and good practices emerging as the new regulations are implemented.

• TBC

Learning Outcomes:

• Understand the key factors that contribute to successful CRF–industry partnerships in clinical trial delivery.
• Recognise and learn from exemplary CRF–industry collaborations across the network.
• Identify opportunities to enhance trial efficiency, quality, and patient impact through industry partnerships.
• Explore practical strategies for overcoming challenges and fostering effective collaboration.
• Define actionable steps for developing effective industry partnerships
• Engage with peers and industry experts to share experiences and celebrate successes

• This meeting brings together CRF Directors to discuss National priorities and updates
• All UK & Ireland CRF Clinical Directors, including Deputies and Co-Directors, are welcome
• Agenda to be confirmed

• TBC

Learning Outcomes:

• Gain insights into research delivery staff and participants’ experiences of trial journeys completion
• Hear practical examples of CRFs improving the research participants end of study experience
• Learn about the workstreams of the UKCRF Network Clinical Research Delivery Group (WP3) ‘End of Study’ Sub-Group to improve end of study experiences

• TBC

Learning Outcomes:

• Become aware of resources to integrate sustainability into research practice
• Learn how clinical research efforts can cascade into sustainable healthcare
• Understand barriers and facilitators to integrating sustainability into how we work
• Gain insight into the role of clinical trials in lifestyle change
• Discover the impact of successful laboratory based initiatives
• Explore evolving sustainability touch points such as Artificial Intelligence, Microplastics

• TBC

Learning Outcomes:

• Gain an insight into the purpose of GCP inspection interviews and how they are conducted
• Explore examples of common questions and what the inspector might be looking for
• Discover tips on how to answer questions and conduct yourself during an interview
• Take part in a Q&A session.

• TBC

Learning Outcomes:

• Be introduced to the UKCRF Network leadership toolkit
• Reflect on personal leadership styles and recognise how different approaches influence engagement and performance in clinical research settings.
• Identify practical actions to strengthen leadership within their own teams and organisations
• Take part in Q&A

• TBC

Learning Outcomes:

• Explore issues, conflicts and errors that arise in an investigators site file.
• Gain insights on how to manage and correct ISF issues, conflicts and errors
• Delegate experience and feedback will support the development of an ISF that can be used for educational and orientation purposes.

• TBC

Learning Outcomes:

• Understand key barriers that limit the participation of under-served populations in clinical trials.
• Gain insight into practical strategies for designing and delivering more inclusive clinical trials.
• Learn about methodological innovations and tools that support equity, diversity and inclusion in clinical research.
• Explore examples of initiatives and training programmes aimed at improving inclusive trial design and conduct.
• Identify approaches that can be applied within their own research to improve representation and engagement in clinical trials.

• TBC

Learning Outcomes:

• Understand and learn about the regulatory Requirements needed to be in place prior to study start and the differences between UK and EU regulations,
• Explore specific aspects surrounding the pharmaceutical management of these novel drugs,
• Design a clinical space dedicated to psychedelic studies,
• Understand the clinical therapeutic requirements that are needed to support participants in their trial, specifically during a dosing visit.

• TBC

Learning Outcomes:

• Understand two key impact frameworks/projects: PPI Ignite Impact Framework and Research Stories Project (Barts Health NHS Trust)
• Describe different types of PPI impact and how to effectively capture and measure impact e.g. via structured evaluation surveys
• Discuss effective methods of creatively communicating PPI impact e.g. via storytelling

• TBC

Learning Outcomes:

• Understanding the challenges of Rare Disease Research
• The importance of International Registries and cross boarder Collaboration in Rare Disease Clinical Research
• Insights from a patients perspective